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Background: Receiving a cancer diagnosis affects family members as well as the person diagnosed. Family
members often provide support for the sick person in daily life out of duty and love, and may not always think
of their own vulnerability to illness. To individualise support for them, family members who are most at risk for
becoming ill must be identified.
The aim of this study was to investigate health-related quality of life (HRQOL) in family members of patients
with advanced lung or gastrointestinal cancer 3 to 15 months after diagnosis.
Methods: Data on mental and physical dimensions of HRQOL were collected from family members of these
patients in this prospective quantitative study. Five assessments using the Short Form 36 Health Survey (SF-36)
and EuroQol (EQ-5D) were conducted during a 1-year period starting 3 months after diagnosis. Thirty-six family
members completed the study, i.e. participated in all five data collections.
Results: No statistically significant changes in physical or mental HRQOL within the study group appeared over
the 1-year follow-up. Compared with norm-based scores, family members had significantly poorer mental HRQOL
scores throughout the year as measured by the SF-36. Family members also scored statistically significantly worse
on the EQ-5D VAS in all five assessments compared to the norm-based score. Findings showed that older family
members and partners were at higher risk for decreased physical HRQOL throughout the 1-year period, and
younger family members were at higher risk for poorer mental HRQOL.
Conclusions: It is well known that ill health is associated with poor HRQOL. By identifying family members with
poor HRQOL, those at risk of ill health can be identified and supported. Future large-scale research that verifies our
findings is needed before making recommendations for individualised support and creating interventions best
tailored to family members at risk for illness.
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The diagnosis of malignant disease causes serious psy-
chological distress to the affected person, and the illness
can have severe consequences for the family [1-4]. Fam-
ily members often spend a lot of time providing the
diseased person with practical and emotional support
during, between and after treatments. Supportive care* Correspondence: gerd.ahlstrom@med.lu.se
3The Swedish Institute for Health Sciences, Department of Health Sciences,
Lund University, Box 187SE–221 00, Lund, Sweden
Full list of author information is available at the end of the article
© 2012 Sjolander et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the orfrom family members, in addition to emotional support,
includes different kinds of assistance, such as help with
household tasks, transportation, medical appointments
and medication management [5,6].
Previous studies on family caregivers of persons with
advanced cancer have shown that their mental health is
negatively affected [7,8]. They are at high risk of becom-
ing anxious and depressed in response to the critical
situation [1,9]. Grunfeld and colleagues [7] have in fact
reported that significantly more family caregivers than
patients are anxious [7]. When health-related quality ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Sjolander et al. Health and Quality of Life Outcomes 2012, 10:89 Page 2 of 13
http://www.hqlo.com/content/10/1/89life (HRQOL) has been evaluated in patients’ family
members, results have been inconsistent. That is, some
studies have shown HRQOL to be negatively affected by
the situation [8,10-12], whereas others have reported
family members’ mental and physical health comparable
to that of the general population [13].
In a review of the literature on effects of caring for a
patient with cancer, emotional and social concerns were
the most identified types of family caregiver problems
[14]. However, there are some knowledge gaps in studies
on specific problems and burdens associated with a
patient’s cancer diagnosis. Less focus in the literature
has been on physical health, with the most prevalent
problems reported being pain, sleep disturbances,
fatigue, loss of appetite and weight loss [15,16]. How-
ever, only a few studies have addressed how caregiver
problems change during different stages in a cancer
patient’s illness trajectory [14]. Therefore, it is important
to learn more about the start of the cancer trajectory
and how it is experienced over time from a family
member’s perspective related to changes and existential
threat [17-20].
Earlier studies on family members’ HRQOL have been
conducted during palliative care starting from the cancer
patient’s diagnosis, with the centre of attention at the
time point close to or after death [11,21].
Those diagnosed with lung or gastrointestinal cancer
have a poor prognosis and low survival rate regardless of
treatment or differences in progression of the disease.
In fact, lung cancer, followed by stomach and liver
cancer, are the most common causes of cancer deaths
worldwide [22]. The poor prognosis associated with
these forms of cancer can mean extra pressure on rela-
tives and may affect family members’ HRQOL. There-
fore, the aim of this study was to investigate HRQOL in
family members of patients with advanced lung or
gastrointestinal cancer over a 1-year period. There is a
need to identify family members who are most at risk
for becoming ill to determine if there is a need for tailored
support for the next of kin. The term “advanced cancer”
in this study is based on a clinical perspective meaning a
severe form of cancer with a high rate of mortality.
Methods
Design
This was a prospective quantitative study designed to
follow mental and physical dimensions of HRQOL in
family members of persons with advanced lung or
gastrointestinal cancer over a 1-year period, beginning
3 months after diagnosis. The study was conducted dur-
ing 2007–2011. Data were collected on five different
occasions, 3, 6, 9, 12 and 15 months after the patient’s
diagnosis, and are termed assessments A1, A2, A3, A4
and A5, respectively.Research ethics
Ethical approval for this study was granted by the
research ethics committee at Linköping University,
Sweden. Informed written consent was obtained from all
participants prior to the study. It was made clear to
them that participation was voluntary, and they were
free to withdraw whenever they wished without any
consequences related to care for themselves or the
cancer patient. Confidentiality was guaranteed, and the
findings could not be linked to the individuals.
Selection of the study group
Family members included in this study had a sick rela-
tive who up to 3 months earlier had been diagnosed with
advanced lung cancer or cancer in the upper gastrointes-
tinal tract at either one medical clinic or one of the two
surgical clinics at two hospitals in the south of Sweden.
Eligible family members had to be aged 18 years of age
or older and able to speak Swedish.
Thirty-six family members completed the study, i.e.
participated in all five data collections. The mean age of
the study group was 63 years (SD= 16 years). The family
members in the study group were next of kin to a pa-
tient with lung cancer (n = 24, 66%) or a patient with
gastrointestinal cancer (n = 12, 34%). Gastrointestinal
cancer in this study included pancreatic, oesophageal,
liver and stomach cancer. In both lung and gastrointes-
tinal cancer, there are several different cancer diagnoses
that lead to different courses of the diseases, but all
involve a poor prognosis. Participant characteristics,
including gender, education, work status and relation-
ship to the patient with cancer, for the study group and
the 21 individuals who dropped out after the study
began are presented in Table 1.
Initially, 200 patients with cancer were asked by one
of eleven nurses or one of two physicians at the three
clinics if they were willing to give written informa-
tion about the study to their closest family member and
ask them to participate (Figure 1). If patients accepted,
they received two letters indicating the purpose and
design of the study, one to themselves and one to the
chosen family member. Sixty-four family members
agreed to participate, but seven of them withdrew
before the study began because the patient was too
ill. Demographic data on those who withdrew prior to
the start of the study (n = 7) were not available. Twenty-
one family members dropped out because the patient
died or became too ill. Two types of calculation were
used to analyse differences between the study group
and drop-outs. First, any significant differences in
demographic data (age, gender, education, occupation or
relationship) were examined (Table 1). Second, differ-
ences in HRQOL between the groups were explored
at baseline. No significant differences were found
Table 1 Characteristics of the study group (n= 36) and
those who dropped out after the study began (n =21)
Study group¤ Drop-outs
n (%) n (%)
Gender
Female 26 (72) 13 (62)
Male 10 (28) 8 (38)
Education
High school and above 24 (66) 16 (76)
Less then high school 12 (33) 5 (24)
Work status
Retired 19 (52) 13 (62)
Currently working 14 (39) 7 (33)
On sick leave from work 3 (9)# 1 (5)#
Applying for a job
Relationship to the person with cancer
Partner 26 (72) 16 (76)
Grown child 8 (22) 4 (19)
Other relative (ex-partner or sibling) 2 (6)# 1 (5)#
Primary caregiver 31 (86) 18 (86)
Not primary caregiver 5 (14)# 3 (14)#
¤The study group participated in all five measurements. Drop-outs
participated in fewer than five measurements.
There was no significant difference in characteristics between the study group
and drop-outs examined with the chi-square test.
#Not tested for a difference between the study group and dropouts.
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in either calculation.
Data collection procedure
Family members who gave their written consent to par-
ticipate were contacted by phone by the first author.
They were then mailed two HRQOL self-report instru-
ments together with a cover letter every 3rd month. To
reduce the number of drop-outs, they were also phoned
1 week before each data collection to remind them that
the questionnaires were going to be mailed again. A
similar reminder was provided 2 weeks after the mailed
questionnaires if their response had not reached the
first author.
Instruments
The two self-report HRQOL instruments used in this
study were the Short Form Health Survey (SF-36) and
the EuroQol (EQ-5D). These instruments were selected
because they are considered complementary in respect
to different variables of similar dimensions.
Health-related quality of life (HRQOL)
The SF-36 is one of the most widely used self-assessment
instruments for measuring HRQOL. It consists of 36items making up eight scales that measure a physical and
a mental health dimension. The physical health dimen-
sion, represented by the Physical Component Summary
Score (PCS), contains the scales Physical Functioning
(PF), Role Physical (role limitations due to physical pro-
blems; RP), Bodily Pain (BP) and General Health (GH).
The mental health dimension, represented by the Mental
Component Summary Score (MCS), contains the scales
Vitality (VT), Social Functioning (SF), Role Emotional
(limitations due to emotional problems; RE) and Mental
Health (MH) [23]. Raw scores were coded, re-calibrated,
summated and transformed from 0 to 100 for each item,
with higher scores reflecting better HRQOL, following
norm values for the general Swedish population. The
eight scales and the two dimensions, PCS and MCS, were
calculated according to the standard SF-36 algorithms
in the test manual [23,24].
The EQ-5D, also a self-assessment instrument, com-
prises five dimensions: mobility, self-care, usual activities,
pain/discomfort and anxiety/depression. The answers
were scored by an algorithm from the EQ-5D manual
[25,26], an index value of HRQOL with higher scores
reflecting better health status. The respondents were also
asked to draw a line on a visual analogue scale (VAS)
thermometer that ranged from the worst imaginable
health state today (0 points) to the best imaginable (100
points). The index value of the EQ-5D can be generated
from the dimensions with a range of −0.594 to 1 by
applying scores from standard population values [27].
Analysis
Family members’ characteristics in the drop-out group
compared with the study group were examined using the
chi-square test. Linear mixed models with repeated obser-
vations and method restricted maximum likelihood were
applied to analyse changes between 3 months and
15 months for family members in separate comparison
analysis of each value, with measure 1 at baseline
(3 months after the patient’s diagnosis). The variable of
age was dichotomised on equal percentiles in two age
groups (20–65 and 66–84 years). Because the study group
was small, two equally sized groups were preferable for
statistical comparisons. Moreover, such classification
meant that the older group came to consist mainly of
retired individuals, and the younger group comprised
mainly people who were economically active. SF-36
dimensions were analysed with the Mann–Whitney U
Test for independent samples between age group and be-
tween family members’ relationship to the patient. Al-
though the analysis was non-parametric, the family
members’ HRQOL on the SF-36 and EQ-5D are presented
in the tables as means, medians and standard errors of the
means to facilitate comparisons to previous studies. The
associations between age and relationship to the patient
                     Participants                         Drop-outs
Family members agreeing to 
participate in the study  
 (n = 64) 
Family members not responding 
about participation in the study  
 (n = 136) 
Family members participating in 
the study from the beginning 
 (n = 57) 
Family members not wanting to 
participate when the patient  
became too ill  
 (n = 7) 
Study group 
Family members who filled in the 
questionnaires at five data 
collections during a one-year 
period 
 (n = 36) 
Family members who did not 
complete all five questionnaires  
because the patient died or was too 
ill # 
 (n = 21)  
Patients newly diagnosed with lung 
or gastrointestinal cancer were 
asked to participate and received 
two letters, one for themselves and 
one to give to a family member 
 (n = 200) 
Figure 1 Flow chart of patients and family members during the study. Note: # Completed questionnaires in the drop-out group varied
between one and four per person, with a total of 51.
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Spearman’s correlation coefficient. A stepwise logistic re-
gression analysis using the forward Wald method was
conducted on all five assessments with the eight scales in
the SF-36 as independent variables and age and relation-
ship as dependent variables. The aim was to describe
which scales had the greatest effect by age and relation-
ship. The significance level was assumed at α=0.05, and
the statistical calculations were carried out in SPSS, ver-
sion 19.1. Statistical differences were tested between
norm-based scores for the SF-36 and EQ-5D and respect-
ive mean scores at A1–A5 using Statistica, version 10. Be-
cause age may be an important factor in HRQOL, it was
important to get a comparable age structure in a compari-
son of scores of the study group and norm-based scores.
Results
Table 2 shows results for physical and mental HRQOL
measured by the SF-36 and EQ-5D on 5 different occa-
sions over 1 year, beginning 3 months after the cancer
diagnosis. There were no statistically significant differencesin HRQOL within the study group over the 15-month
follow-up.
Table 2 also shows a comparison of norm-based scores
with HRQOL scores. Mean scores for the Physical Com-
ponent Summary and the four scales (Physical Function-
ing, Role Physical, Bodily Pain and General Health)
of the SF-36 during follow-up were similar or higher
compared with the norm-based scores. However, the
Physical Component Summary Score was statistically sig-
nificantly different (p< 0.05) only at A2. There were sta-
tistically significant lower mean scores compared with
norm-based scores for the EQ-5D VAS at all assessments
(A1–A5), but only at A5 for the EQ-5D Index (Table 2).
The mean scores for the Mental Component Summary
as well as the four scales (Vitality, Social Functioning,
Role Emotional and Mental Health) were lower than
norm-based scores at all five assessments. These differ-
ences were statistically significant (p< 0.05), except for
Role Emotional at A4.
Table 3 shows significant differences in SF-36 dimensions
and scales between the two age groups (20–65 66–84 years).
Table 2 HRQOL scores of family members at five assessments compared to norm-based scores (n = 36)
Norm-based





























PCS □44.6 [±1.02] 45 46 [±1.9] 52 49 [±2.0]* 0.33 48 46 [±1.8] 0.96 48 45 [±2.0] 0.66 51 47 [±2.0] 0.66
MCS □51.1 [±0.97] 38 39 [±2.2]* 44 42 [±2.5]* 0.53 38 39 [±2.4]* 0.91 45 43 [±2.2]* 0.25 45 41 [±2.4]* 0.71
PF □78.2 [±1.94] 83 79 [±3.6] 90 83 [±3.2] 0.42 89 80 [±3.2] 0.77 85 80 [±3.4] 0.85 90 81 [±3.6] 0.69
RP □70.1[±3.42] 75 63 [±6.4] 100 74 [±6.4] 0.22 88 60 [±7.7] 0.77 75 62 [±7.2] 0.89 88 66 [±7.1] 0.76
BP □66.0 [±2.35] 56 63 [±4.8] 62 67 [±4.4] 0.55 52 63 [±4.2] 0.95 51 60 [±4.9] 0.67 62 64 [±4.2] 0.82
GH □67.2 [±2.04] 59 60 [±3.4] 67 64 [±3.1] 0.33 65 62 [±3.1] 0.65 67 62 [±3.5] 0.63 67 65 [±3.6] 0.28
VT □67.3 [±2.09] 48 50 [±3.3]* 58 57 [±3.9] * 0.19 50 54 [±3.9]* 0.47 58 55 [±4.0]* 0.39 58 55 [±3.7]* 0.36
SF □88.3 [±1.73] 75 74 [±4.3]* 94 79 [±4.2] * 0.45 69 70 [±4.3]* 0.46 81 77 [±4.2]* 0.68 88 77 [±4.3]* 0.68
RE □81.6 [±2.86] 67 58 [±7.3]* 100 69 [±6.7] * 0.30 83 60 [±7.7]* 0.88 100 75 [±6.0] 0.08 84 61 [±7.6]* 0.82
MH □80.5 [±1.68] 64 62 [±3.4]* 66 65 [±4.0] * 0.58 60 63 [±3.6] * 0.79 68 63 [±3.7]* 0.83 66 64 [±3.7]* 0.70
EQ5D Index #0.8 [±0.01] 0.80 0.73 [±0.04] 0.76 0.75 [±0.03] 0.91 0.73 0.73 [±0.04] 0.50 0.80 0.72 [±0.04] 0.71 0.80 0.70 [±0.04]* 0.35
EQ-5D VAS #79.7 [±0.83] 75 73 [±3.0]* 79 74 [±2.8]* 0.76 75 70 [±3.4]** 0.98 75 71[±3.0]** 0.91 70 69 [±3.3]** 0.61
A1 = 3 months, A2 = 6 months, A3 = 9 months, A4 = 12 months, A5 = 15 months.
Data at A2–A5 were compared with data at A1 (linear mixed models for repeated observations).
□ Norm-based score =Norms for the general Swedish population (age group 60–64 years), Sullivan et al. 2002. # Norm-based score =UK population norms for the EQ-5D (age group 55–64 years), Kind et al. 1999.
PCS = Physical Component Summary Score, MCS =Mental Component Summary Score, PF = Physical Functioning, RP = Role Physical, BP = Bodily Pain, GH=General Health, VT = Vitality, SF = Social Functioning, RE = Role
Emotional, MH=Mental Health, EQ-5D Index = EQ-5D index score, EQ-5D VAS = EQ-5D visual analog scale.














































20-65 years 55 52 [±2.3] 0.006** 56 55 [±2.7] 0.003** 50 50 [±2.1] 0.025* 52 50 [±2.7] 0.005** 54 52 [±2.7] 0.011*
66-84 years 40 41 [±2.5] 45 44 [±2.5] 42 42 [±2.6] 41 39 [±2.6] 45 42 [±2.4]
MCS
20-65 years 35 33 [±2.8] 0.007** 37 35 [±4.3] 0.036 36 35 [±4.0] 0.147 44 40 [±3.0] 0.117 40 36 [±3.9] 0.078
66-84 years 47 45 [±2.9] 47 47 [±2.3] 41 42 [±2.7] 49 46 [±3.0] 47 45 [±2.7]
PF
20-65 years 100 89 [±5.1] <0.001*** 100 94 [±2.7] <0.001*** 95 86 [±4.4] 0.012* 100 91 [±3.3] 0.001** 95 91 [±3.6] 0.006**
66-84 years 69 70 [±4.2] 75 74 [±4.9] 73 72 [±4.4] 75 69 [±4.7] 78 72 [±5.4]
RP
20-65 years 100 79 [±6.8] 0.021* 100 87 [±8.0] 0.107 100 68 [±10.3] 0.321 100 72 [±10.2] 0.174 75 71 [±10.2] 0.458
66-84 years 50 49 [±9.5] 75 67 [±9.2] 75 53 [±11.2] 50 53 [±10.0] 100 61 [±10.0]
BP
20-65 years 61 65 [±7.0] 0.649 72 71 [±7.1] 0.699 51 63 [±7.8] 0.440 57 66 [±6.8] 0.651 73 69 [±7.0] 0.271
66-84 years 41 60 [±6.8] 62 66 [±6.4] 51 57 [±6.3] 52 59 [±5.4] 57 60 [±4.9]
GH
20-65 years 62 62 [±4.8] 0.622 67 70 [±4.0] 0.303 77 68 [±5.2] 0.232 65 65 [±4.9] 0.070 70 70 [±5.1] 0.283
66-84 years 57 58 [±4.8] 67 61 [±4,8] 57 57 [±4.4] 62 57 [±4.0] 65 61 [±4.9]
VT
20-65 years 40 42 [±4.2] 0.013 55 51 [±6.2] 0.221 48 50 [±6.7] 0.726 55 54 [±5.0] 0.645 53 50 [±6.3] 0.341
66-84 years 65 58 [±4.2] 60 61 [±5.2] 50 54 [±4.4] 60 56 [±6.2] 60 59 [±4.2]
SF
20-65 years 75 68 [±6.4] 0.141 75 73 [±7.5] 0.262 83 64 [±7.0] 0.478 88 75 [±6.4] 0.646 75 72 [±6.6] 0.265
66-84 years 88 79 [±5.6] 100 83 [±5.3] 69 71 [±5.3] 75 78 [±5.6] 93 81 [±5.7]
RE
20-65 years 67 57 [±11.0] 0.878 100 60 [±11.8] 0.208 67 56 [±12.1] 0.694 100 76 [±8.5] 0.986 67 52 [±12.2] 0.286
66-84 years 67 59 [±10.1] 100 76 [±8.0] 83 63 [±10.0] 100 74 [±8.7] 100 68 [±9.5]
MH
20-65 years 50 53 [±4.0] 0.006 52 57 [±5.8] 0.061 56 57 [±6.4] 0.240 60 58 [±5.4] 0.193 62 60 [±6.1] 0.436























Table 3 HRQOL scores by age groups (n =18 each) at 3 to 15 months (n =36) (Continued)
EQ-5D Index
20-65 years 0.82 0.74 [±0.05] 0.591 0.73 0.73 [±0.05] 0.652 0.76 0.75 [±0.06] 0.392 0.80 0.80 [±0.05] 0.403 0.80 0.71 [±0.06] 0.254
66-84 years 0.73 0.72 [±0.05] 0.80 0.80 [±0.05] 0.73 0.71 [±0.04] 0.78 0.78 [±0.05] 0.76 0.70 [±0.06]
EQ-5D VAS
20-65 years 70 74 [±5.3] 0.774 70 70 [±4.6] 0.373 75 67 [±6.6] 0.973 75 73 [±4.3] 0.679 60 62 [±5.7] 0.115
66-84 years 75 72 [±3.5] 80 80 [±3.5] 75 72 [±3.0] 75 70 [±4.2] 80 75 [±3.3]
Independent Samples Mann–Whitney U Test * p< 0.05, ** p< 0.01, *** p< 0.001, ns = not significant.
A1 = 3 months, A2 = 6 months, A3 = 9 months, A4 = 12 months, A5 = 15 months.
PCS = Physical Component Summary Score, MCS =Mental Component Summary Score, PF = Physical Functioning, RP = Role Physical, BP = Bodily Pain, GH =General Health, VT = Vitality, SF = Social Functioning, RE = Role














































Partners 41 43 [±2.2] 0.015* 46 44 [±2.2] 0.006** 43 42 [±2.1] 0.019* 44 41 [±2.2] <0.001*** 48 44 [±2.1] 0.002**
Children 55 54 [±3.4] 57 58 [±1.8] 56 55 [±1.9] 56 56 [±7] 57 58 [±3.9]
PF
Partners 75 74 [±2.8] 0.002** 80 77 [±4.1] 0.001** 73 73 [±3.8] 0.007** 75 72 [±3.8] # 80 75 [±4.3] 0.001**
Children 100 89 [±9.9] 100 99 [±1.3] 100 94 [±4.9] 100 100 [±0.0] 100 98 [±1.5]
RP
Partners 50 54 [±7.8] 0.181 75 66 [±8.4] 0.010* 50 53 [±9.2] 0.007** 63 57 [±8.6] <0.001*** 75 63 [±8.2] 0.001**
Children 100 84 [±8.1] 100 97 [±3.1] 100 84 [±12.4] 100 81 [±12.3] 100 82 [±14.1]
BP
Partners 41 56 [±5.7] 0.074 62 62 [±5.7] 0.175 51 55 [±4.5] 0.060 41 52 [4.9] <0.007** 51 58 [±4.3] 0.004**
Children 92 82 [±8.0] 78 78 [±7.8] 92 81 [±8.4] 100 87 [±10.9] 100 89 [±8.4]
GH
Partners 57 59 [±4.2] 0.283 67 60 [±4.2] 0.205 62 56 [±3.2] 0.019* 60 56 [±3.8] 0.020* 67 61 [±4.0] 0.034*
Children 67 67 [±5.8] 70 72 [±2.7] 80 73 [±8.0] 80 78 [±7.0] 87 82 [±6.7]
VT
Partners 58 54 [±4.1] 0.148 55 59 [±4.3] 0.502 50 54 [±3.8] 0.413 60 55 [±5.0] 0.596 60 56 [±4.0] 0.567
Children 45 42 [±4.3] 58 50 [±10.8] 65 59 [±10.5] 58 62 [±5.5] 70 60 [±8.6]
SF
Partners 88 76 [±5.4] 0.383 100 84 [±4.6] 0.043 69 72 [±4.3] 0.804 75 78 [±4.5] 0.983 88 81 [±4.7] 0.226
Children 75 72 [±7.4] 56 61 [±11.4] 69 69 [±9.4] 88 77 [±10.1] 75 66 [±10.8]
RE
Partners 50 53 [±8.9] 0.222 78 75 [±7.0] 0.258 83 61 [±8.9] 0.850 100 74 [±7.2] 0.709 67 60 [±8.8] 0.729
Children 100 75 [±13.7] 67 54 [±17.7] 83 58 [±17.5] 100 83 [±8.9] 75 66 [±10.8]
MH
Partners 68 65 [±4.1] 0.103 68 69 [±4.5] 0.148 60 62 [±3.7] 0.881 68 65 [±4.0] 0.919 72 66 [±4.2] 0.749
Children 51 53 [±6.3] 46 54 [±10.0] 74 70 [±9.6] 73 65 [±7.8] 100 67 [±17.8]
EQ-5D Index
Partners 0.73 0.70 [±0.46] 0.068 0.76 0.76 [±0.04] 0.680 0.73 0.70 [±0.04] 0.011* 0.76 0.69 [±0.04] 0.002** 0.73 0.67 [±0.05] 0.001**























Table 4 HRQOL scores by partners (n =26) and children (n= 8) at 3 to 15 months (n =36) (Continued)
EQ-5D VAS
Partners 75 73 [±2.8] 0.415 80 76 [±2.8] 0.318 75 71 [±2.9] 0.365 75 70 [±3.5] 0.107 79 71 [±3.7] 0.292
Children 78 72 [±10.3] 67 65 [±8.7] 83 73 [±9.6] 78 81 [±3.8] 63 65 [±6.5]
Independent Samples Mann–Whitney U Test * p <0.05, ** p <0.01, *** p <0.001.
A1 = 3 months, A2 = 6 months, A3 = 9 months, A4 = 12 months, A5 = 15 months.
PCS = Physical Component Summary Score, MCS =Mental Component Summary Score PF = Physical Functioning, RP = Role Physical, BP = Bodily Pain, GH =General Health, VT = Vitality, SF = Social Functioning, RE = Role
Emotional, MH=Mental Health, EQ-5D Index = EQ-5D Index score, EQ-5D VAS = EQ-5D Visual analog scale.
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higher scores, i.e. better HRQOL, on the Physical Compo-
nent Summary and Physical Functioning scale over the
complete follow-up period than respondents aged 66–
84 years. Table 3 also shows that even though the younger
age group had better physical HRQOL, they had worse
mental HRQOL scores during the follow-up period, al-
though only statistically significant at 3 months for the Men-
tal Component Summary.
Table 4 depicts comparisons between partners and
children of the cancer patients with regard to the phys-
ical and mental scales during the study period. As
shown, children scored statistically significantly higher
on the Physical Component Summary than partners at
all five assessments. Table 4 also shows that children had
higher values than partners on the EQ-5D index, but dif-
ferences were statistically significant only at 9, 12 and
15-month assessments (A3–A5). In summary, results
showed that older age (Table 3) and being a partner
(Table 4) had a negative influence on HRQOL, especially
on the Physical Component Summary Score and Phys-
ical Functioning scale.
Nearly 56% of all partners were in the age range of
66–84 years, and 20% of the children were 20–65 years
of age. There was a clear relationship between the part-
ner variable and age variable (Rs = 0.6). The logistic
regression analysis showed an age group effect on
HRQOL for Physical Functioning at all five assessments:
at A1 (p = 0.008, OR= 0.9), A2 (p = 0.007, OR= 0.8), A3
(p = 0.04, OR= 0.95), A4 (p = 0.004, OR= 0.9) and A5
(p = 0.01, OR= 0.9). At A1 age group explained differ-
ences in Vitality (p = 0.01, OR= 1.1), at A2 Role Physical
(p = 0.02, OR= 1.1), and at A5 Role Emotional (p = 0.04,
OR= 1.03). These results verify that age had the greatest
effect on lower Physical Functioning scores, and can
therefore be seen as a confounder to the explanation of
the effect of cancer diagnosis on family members.
Discussion
The present study revealed that family members of a
person with lung or gastrointestinal cancer had poorer
functioning on the mental dimension of HRQOL, com-
pared with norm-based scores, indicating they felt worse
than the general population [23,26]. Findings related
to mental health-related quality of life measured by the
SF-36 were considered clinically significant when 18 of
20 scale scores reflected a 10-point difference from
norm-based scores. Standards for determining clinically
significant change over time varies between different
populations and is related to expectations of change.
However, several studies have recommended 10 as an
approximate cut-off representing a small change, 20 for
a moderate change and 30 for a large change on scales
of the SF-36 [28,29]. Our results on mental HRQOL, interms of clinical relevance, highlight the importance of
physicians and health care professionals providing sup-
port measures integrated into treatment and care.
Findings related to degree of change in the SF-36
physical dimension compared to the mental dimension
were not consistently the same. The statistically signifi-
cant difference in the EQ-5D VAS compared to the
norm-based score represented an unequivocal pattern in
all five assessments. However, the clinical significance
of such findings was less clear, given that only three
of the five assessments showed a difference in score of
10 points compared with the norm-based score. This
result needs to be verified in large-scale studies in the
future. This recommendation is supported by the review
by Swore Fletcher and colleagues [16] that identified
very few published studies about cancer’s impact on
family caregivers’ physical health.
It is well-known that a cancer diagnosis is distressing
not only for the sick person, but for close family as well.
Previous research has shown a negative effect of the
cancer diagnosis on the mental health dimension of
HRQOL for family members with symptoms such as
anxiety and depression [2,8,9,30,31]. Results reported by
Persson and colleagues [11] are consistent with our find-
ing that family members scored significantly lower on
the mental dimension scales compared to the norm-
based scores [11]. The literature reflects an interest in
generating knowledge about how coping influences
mental health. In a study by Sjölander and colleagues
[32], findings showed that family members of a person
with advanced lung or gastrointestinal cancer strive to
prepare themselves mentally for the anticipated tragedy
and use several different management strategies to cope
with the menacing future. These results are in line with
several previous studies [11,32,33]. However, there is a
need for more knowledge about family members’ coping
strategies and their influence on HRQOL [34].
This study identified three groups of family members
vulnerable to illness. Older age had a negative effect on
HRQOL compared with younger age. This was especially
seen in the Physical Component Summary Score and
Physical Functioning scale, with significant differences in
all five assessments (Table 3). Earlier studies have shown
that the Physical Functioning scale, which measures lim-
itations in performing daily activities, has a strong asso-
ciation with aging [23,35]. Our results regarding poorer
scores for physical HRQOL in older family members
verify results of Kim and colleagues [13,36]. Analyses
at item level in this study revealed that age explained
the decreased HRQOL, especially for items that reflect
more strenuous physical activities in the physical dimen-
sion. This result is consistent with the physical fragility
in older age, which is well described in the literature
[37-39]. This is in accordance with results of the logistic
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one factor in assessing physical functioning at all five
measurement times.
In contrast, younger family members had worse men-
tal HRQOL scores during the follow-up period in our
study. This was shown in the Mental Component Sum-
mary Score when it was compared with the norm-based
score for the same age group in a population sample in
a study by Sullivan and colleagues [23]. Worse mental
health in younger persons with illness compared with
older persons has also been shown previously [40]. In a
review by Harden and colleagues [41], caregivers in late
middle age (50–64 years) seemed to have more problems
with mental health and psychological well-being than
older caregivers [41]. Younger caregivers may experience
more social and economic problems, resulting in
increased anxiety and depression [42,43] as well as nega-
tive effects on their family life [44]. This was supported
in our study, with younger persons’ mental health scores
remaining low for the duration of the study.
The third group of family members identified as vul-
nerable in this study were partners of the patient, par-
ticularly with regard to their physical health. As their
closest support, partners have a vital role in the care of
the diagnosed person, [1,9,31,45,46]. In our study, part-
ners had worse scores for the physical health dimension
than did the children. However, age might have had an
influence on this result, given that most partners (56%)
were older (66–84 years), with worse scores on physical
health possibly owing to physical fragility in older adults.
Methodological considerations
The study population included relatively few family
members and resulted in low power in detecting small
changes over time and differences between subgroups in
the population. This was the case, despite our recruit-
ment of family members from two medium-sized hospi-
tals and a rather long inclusion period (2007–2010).
There were drop-outs both before the start of the study
and during the study. The selection of family members
was accomplished through assistance by staff (nurses
and physicians) who initially asked the patients and sec-
ondly by the patients who asked their family member
about participation. This procedure explains why there
is no information about the reasons for drop-outs and
demographic data of the initial 200 family members or
the seven that dropped out right after consenting to par-
ticipate. Despite several reminders provided during the
data collection procedure to prevent drop-outs, the ini-
tial recruitment could have been done differently. The
initial number who dropped out might have been
reduced if the family members had been approached
personally by the researcher or only one responsible
nurse at each hospital.Of the 57 family members entering the investigation, a
total of 36 completed the study with participation in all
five data collections. Analysis of drop-outs showed that
the 21 family members who dropped out during the
study were not significantly different in age, gender, edu-
cation, occupation or relationship from those who com-
pleted the study. In addition, a strength of the data is
that there was no difference in HRQOL or EQ5D at
baseline between drop-outs after the start of the study
and the study group who participated in all five data col-
lections, which reduces the chance that the study was
not representative. However, the large non-response rate
makes uncertain the study’s generalisability, which must
be kept in mind when interpreting the results.
Another reason for the low statistical power [47] was
the authors’ decision to include only family members
who filled in the questionnaires in all five data collec-
tions. The authors assessed it as better if the same indi-
viduals were included in the comparison over time than
comparing groups of individuals in which the size
decreased because of drop-outs. Seeing changes over
time can result in more reliable data. Even though the
power could have increased if all individuals were
included, uncertainty would increase because there was
no single group. The drop-outs during the study were
explained by increased sickness in the patients, a factor
that was out of our control during the year-long data
collection. This reason for drop-outs has been previously
described in the literature related to severe or advanced
cancer patients [11,21]. Therefore, the performed statis-
tical analyses were less powerful, and logistic regression
analysis should be considered from a descriptive per-
spective. In addition, the findings of the logistic regres-
sion analysis of type of relation on HRQOL were not
included in the results because of a large difference in
group size (partners, n = 28 and children, n = 8). The
ability to predict values for the group of children was
relatively low with percentage correct 50–62% compared
with the analysis of partners (percentage correct 83%)
and age (percentage correct 85%).
When a large number of comparisons are statistically
examined, there is a risk of mass significance. With an
alpha-level of .05, the risk for random significance is 1 in
20. One way to diminish the risk of mass significance is
to lower the alpha level. Procedures used to calculate a
new alpha level are Bonferroni’s test and the Dunn-Sidak
correction [47]. However, in this study the authors deter-
mined that these tests would be too conservative and
might increase the possibility of a type II statistical error.
For this reason, weak or solitary significances should be
considered with some scepticism. Furthermore, the col-
lected data are ordinal-level and not equidistant, and
thus there is a risk of bias in evaluating the size of
changes [48] owing to the uneven distribution of such
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based on the patterns of significant differences that were
in the same direction without deviant values. Linear
mixed models can be used to describe nonlinear rela-
tionships across time in a longitudinal dataset with mul-
tiple missing data points. The strengths of the mixed
models are the ability to accommodate missing data
points and the ability to model nonlinear, individual
characteristics. The mixed model emphasises patterns of
change and individual differences and assumes not a
normal distribution but rather systematic change.
The proportion of men in the study group of family
members was low, which might be explained by the
selection method. Both sexes were represented in nurses
(females) and physicians (males) who asked about par-
ticipation. However, 26 of the 36 patients who asked one
of their family members to participate were males (72%),
and 20 of them (77%) chose a female partner. Six of the
males chose a grown child, and five of those were
daughters. Cancer incidence and mortality in Europe
predominately involves men with lung or upper gastro-
intestinal tract cancer [49]. These cancer diagnoses are
the most common worldwide among men and constitute
42% of new cases and 48% of total cancer deaths. Given
that a diagnosis of lung or upper gastrointestinal tract
cancer is more common among men, it seems reason-
able that our study group was predominately male can-
cer patients and female family members.
The longitudinal design [50] was appropriate for
studying the dynamics of the variables over time given
that cancer patients’ serious illness progresses rapidly
and may affect the family members [50]. The 1-year
follow-up period was considered appropriate in respect
to investigating outcomes for family members dealing
with the mortality of an advanced cancer patient.
Conclusions
There were no statistically significant changes in physical
or mental HRQOL in the study group over the one-year
follow-up. The family members had poorer mental
HRQOL scores throughout the period as measured by
the SF-36 compared with the norm-based scores. In
addition, mean scores for the EQ-5D VAS were statisti-
cally significantly lower at all assessments compared
with norm-based scores. The results suggest that older
family members of cancer patients are at higher risk for
decreased physical HRQOL, especially if they are the
partner. Younger family members are more vulnerable
to decreased mental HRQOL. Older family members
seem to cope with the situation more effectively than
younger persons who show decreased mental HRQOL.
This indicates that support programmes for younger
family members need to focus more on emotional
aspects. However, there is a need for larger-scale researchbefore conclusions can be drawn regarding interven-
tions individually tailored for family members vulnerable
to illness.
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